CLINICAL_TRIALS
trial_result
· 2017-02-24
Clinical Trial Update: Efficacy and Safety of Insulin Detemir in Type 1 Diabetes [Phase 3]
Summary
A Phase 3 trial evaluating the efficacy and safety of insulin detemir in type 1 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED